查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1338878

心臟标记测试市场、份额、规模、趋势、行业分析报告：按产品类型、最终用户、地区、细分市场、预测，2023-2032 年

Cardiac Marker Testing Market Share, Size, Trends, Industry Analysis Report, By Product (Reagents and Kits and Instruments); By Biomarker Type; By End-User; By Region; Segment Forecast, 2023-2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，到 2032 年，全球心臟标记检测市场规模预计将达到 97.3 亿美元。该报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

全球急诊室 (ED) 心血管疾病患者数量激增、需求不断增长以及 POCT 等多种心臟生物标记测试的采用是推动全球市场成长的突出因素。此外，新进业者不断进入测试市场以实现利润最大化，而现有参与者则专注于透过投资研发活动来开发和扩大其产品组合。例如，2023年1月，Cipla宣布推出一款名为 "Cippoint" 的新测试设备，这是一款获得CE IVD批准的床边测试设备，可提供糖尿病、传染病、甲状腺功能、发炎和代谢标誌物的测试。

此外，心臟标记物的最新进展提高了特异性和可靠性，从市售仪器到心肌肌钙蛋白和利尿钠□等新技术，并允许在一次测定中对大量分子靶标进行多重检测。-护理免疫测定的性能得到改善。千禧世代不健康食品消费的增加导致心绞痛患者数量增加，心臟生物标记的采用将迅速增加，以满足该患者群体不断增长的需求。

癌症和各种其他疾病的盛行率显着增加，各国政府将时间和资源集中在开发医疗保健系统和取得先进的心臟标记检测设备。例如，在美国心臟病学会进行的一项新研究中，研究人员认为ApoB 检测可以帮助识别可能处于高心血管风险的患者，即使他们的LDL 胆固醇水平不正常。我发现了一些可能有帮助的东西。

心臟标记测试市场报告亮点

由于心臟生物标记测试的采用增加，2022 年全球市场份额将由试剂和试剂盒主导

肌钙蛋白 I 和 T 细分市场在 2022 年占据了重要的市场收入份额，这主要是由于对这些用于诊断急性心肌梗塞的设备的需求不断增加。

由于主要医疗保健服务提供者的使用量不断增加，预计在研究期间，护理点设施部分将以最高的复合年增长率增长。

由于美国和加拿大等国家在医疗保健基础设施方面的高额支出以及先进心臟生物标记的快速采用，北美地区将在 2022 年主导全球市场。

目录

第 1 章 简介

第二章执行摘要

第三章研究方法论

第四章全球心臟标记检测市场洞察

  • 心臟标记测试市场—生物标记类型概况
  • 心臟标记测试市场动态
    • 驱动因素和机遇
      • 心血管疾病发生率上升
      • 先进技术进步
    • 限制因素和挑战
      • 样本采集与储存的技术问题
  • PESTEL 分析
  • 心臟标记检测市场中生物标记类型的趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第五章全球心臟标记测试市场（按产品）

  • 主要发现
  • 介绍
  • 试剂和试剂盒
  • 设备

第六章全球心臟标记检测市场（按应用）

  • 主要发现
  • 介绍
  • 临床检测设施
  • 即时侦测设施
  • 学术机构

第七章全球心臟标记测试市场（按生物标记类型）

  • 主要发现
  • 介绍
  • 肌钙蛋白 I 和 T
  • 肌酸激□-MB (CK-MB)
  • 钠化合物
  • 肌红蛋白
  • 高敏C反应蛋白
  • 其他心臟生物标记

第八章全球心臟标记测试市场（按地区）

  • 主要发现
  • 介绍
    • 2019-2032 年心臟标记检测市场评估（按地区）
  • 心臟标记测试市场 - 北美
    • 北美：心臟标记测试市场（按产品），2019-2032
    • 北美：心臟标记测试市场，按生物标记类型，2019-2032
    • 北美：心臟标记测试市场，按应用分类，2019-2032
    • 心臟标记测试市场—美国
    • 心臟标记测试市场 - 加拿大
  • 心臟标记测试市场 - 欧洲
    • 欧洲：心臟标记测试市场（按产品），2019-2032
    • 欧洲：心臟标记测试市场，依生物标记类型，2019-2032
    • 欧洲：心臟标记测试市场，按应用划分，2019-2032
    • 心臟标记测试市场—英国
    • 心臟标记测试市场—法国
    • 心臟标记测试市场 - 德国
    • 心臟标记测试市场—义大利
    • 心臟标记测试市场—西班牙
    • 心臟标记测试市场 - 荷兰
    • 心臟标记测试市场—俄罗斯
  • 心臟标记测试市场 - 亚太地区
    • 亚太地区：心臟标记测试市场（按产品），2019-2032
    • 亚太地区：心臟标记测试市场（按生物标记类型），2019-2032 年
    • 亚太地区：心臟标记测试市场（按应用），2019-2032 年
    • 心臟标记测试市场 - 中国
    • 心臟标记测试市场—印度
    • 心臟标记物测试市场 - 马来西亚
    • 心臟标记检测市场—日本
    • 心臟标记测试市场 - 印度尼西亚
    • 心臟标记检测市场—韩国
  • 心臟标记测试市场—中东和非洲
    • 中东和非洲：心臟标记测试市场（按产品），2019-2032
    • 中东和非洲：心臟标记测试市场（按生物标记类型），2019-2032
    • 中东和非洲：心臟标记测试市场，按应用分类，2019-2032
    • 心臟标记测试市场 - 沙乌地阿拉伯
    • 心臟标记测试市场—阿拉伯联合大公国
    • 心臟标记测试市场—以色列
    • 心臟标记测试市场—南非
  • 心臟标记测试市场—拉丁美洲
    • 拉丁美洲：心臟标记测试市场（按产品），2019-2032 年
    • 拉丁美洲：心臟标记测试市场（按生物标记类型），2019-2032 年
    • 拉丁美洲：心臟标记测试市场，按应用划分，2019-2032 年
    • 心臟标记测试市场—墨西哥
    • 心臟标记测试市场 - 巴西
    • 心臟标记测试市场—阿根廷

第9章 竞争格局

  • 扩张和收购分析
    • 扩张
    • 获得
  • 伙伴关係/协作/协议/揭露

第十章公司简介

  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Danaher Corporation
  • Siemens Healthineers
  • Becton Dickson
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • LSI Medience
  • Quidel Corporation
  • Randox Laboratories
  • PerkinElmer
  • Tosoh Corporation
  • Alfa Scientific Designs
  • Response Biomedical
  • Creative Diagnostics
Product Code: PM3322

The global cardiac marker testing market size is expected to reach USD 9.73 billion by 2032, according to a new study by Polaris Market Research. The report "Cardiac Marker Testing Market Share, Size, Trends, Industry Analysis Report, By Product (Reagents and Kits and Instruments); By Biomarker Type; By End-User; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rapid increase in the number of cardiovascular disease patients globally in the emergency departments (EDs), the rising demand and adoption for several cardio biomarkers test like POCT, are prominent factors propelling the global market growth. Moreover, new players are continuously entering into the market with tests in order to generate maximum revenues and established players are focusing on developing and expanding their portfolio by investing in R&D activities, that are further anticipated to create growth opportunities. For instance, in January 2023, Cipla, introduced its new testing devices named 'Cippoint', a CE IVD-approved point-of-care testing device that offers testing for diabetes, infectious diseases, thyroid function, inflammation, and metabolic markers.

Moreover, the recent advances in the cardiac markers from the commercial devices to emerging technologies such as cardiac troponin and natriuretic peptides and Point-Of-Care immunoassays with improved specificity and reliability by enabling the multiplexing through the numerous molecular targets in single assays. The rising consumption of several types of unhealthy food products among millennials resulting in high number of angina pectoris cases, thus to cater the surging demand from these patient pool, adoption of cardiac biomarkers will increase rapidly.

With the drastic increase in the prevalence for cancer diseases and various other disorders and governments are heavily investing their time and money towards the development of their healthcare systems and access to advanced cardiac markers testing devices. For instance, according to a new study done by American College of Cardiology, researchers found that ApoB testing might help in the identification of patients who may still be at the high risk of cardiovascular without having normal LDL cholesterol levels.

Cardiac Marker Testing Market Report Highlights

Reagents and kits segment accounted for major global market share in 2022, on account on increasing adoption of the cardiac biomarker tests

Troponin I and T segment held the significant market revenue share in 2022, mainly due increasing demand for these devices to diagnose acute myocardial infraction

Point-of-care facilities segment is projected to grow at a highest CAGR over the study period, that is highly attributable to its growing utilization among major healthcare service providers

North America region dominated the global market in 2022, owing to high spending on healthcare infrastructure and quick adoption of advanced cardiac biomarkers in countries like US and Canada

The global key market players include: Bio-Rad Laboratories, Thermo Fisher Scientific, Abbott Laboratories, Danaher Corporation, Medtronic PLC; Stryker Corporation; Zimmer-Biomet Holdings, Inc.; DePuy Synthes; Smith and Nephew PLC; Aesculap Implant Systems, LLC; Conmed Corporation; Donjoy, Inc.; NuVasive, Inc. and Roche

Polaris Market Research has segmented the cardiac marker testing market report based on product, biomarker type, end-user, and region:

Cardiac Marker Testing, Product Outlook (Revenue - USD Billion, 2018 - 2030)

  • Reagents and Kits
  • Instruments

Cardiac Marker Testing, Biomarker Type Outlook (Revenue - USD Billion, 2018 - 2030)

  • Troponin I and T
  • Creatine Kinase-MB (CK-MB)
  • Natriuretic Peptide
  • Myoglobin
  • High Sensitivity C-Reactive Protein
  • Other Cardiac Biomarkers

Cardiac Marker Testing, End-User Outlook (Revenue - USD Billion, 2018 - 2030)

  • Laboratory Testing Facilities
  • Point-Of-Care Testing Facilities
  • Academic Institutions

Cardiac Marker Testing, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cardiac Marker Testing Market Insights

  • 4.1. Cardiac Marker Testing Market - Biomarker Type Snapshot
  • 4.2. Cardiac Marker Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising incidence of cardiovascular diseases
      • 4.2.1.2. High technological advancements
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Technical issues related to sample collection and storage
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Cardiac Marker Testing Market Biomarker Type Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Cardiac Marker Testing Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • 5.3. Reagents and Kits
    • 5.3.1. Global Cardiac Marker Testing Market, by Reagents and Kits, by Region, 2019-2032 (USD Billion)
  • 5.4. Instruments
    • 5.4.1. Global Cardiac Marker Testing Market, by Instruments, by Region, 2019-2032 (USD Billion)

6. Global Cardiac Marker Testing Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • 6.3. Laboratory Testing Facilities
    • 6.3.1. Global Cardiac Marker Testing Market, by Laboratory Testing Facilities, by Region, 2019-2032 (USD Billion)
  • 6.4. Point-Of-Care Testing Facilities
    • 6.4.1. Global Cardiac Marker Testing Market, by Point-Of-Care Testing Facilities, by Region, 2019-2032 (USD Billion)
  • 6.5. Academic Institutions
    • 6.5.1. Global Cardiac Marker Testing Market, by Academic Institutions, by Region, 2019-2032 (USD Billion)

7. Global Cardiac Marker Testing Market, by Biomarker Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • 7.3. Troponin I and T
    • 7.3.1. Global Cardiac Marker Testing Market, by Troponin I and T, By Region, 2019-2032 (USD Billion)
  • 7.4. Creatine Kinase-MB (CK-MB)
    • 7.4.1. Global Cardiac Marker Testing Market, by Creatine Kinase-MB (CK-MB), By Region, 2019-2032 (USD Billion)
  • 7.5. Natriuretic Peptide
    • 7.5.1. Global Cardiac Marker Testing Market, by Natriuretic Peptide, By Region, 2019-2032 (USD Billion)
  • 7.6. Myoglobin
    • 7.6.1. Global Cardiac Marker Testing Market, by Myoglobin, By Region, 2019-2032 (USD Billion)
  • 7.7. High-Sensitivity C-Reactive Protein
    • 7.7.1. Global Cardiac Marker Testing Market, by High-Sensitivity C-Reactive Protein, By Region, 2019-2032 (USD Billion)
  • 7.8. Other Cardiac Biomarkers
    • 7.8.1. Global Cardiac Marker Testing Market, by Other Cardiac Biomarkers, By Region, 2019-2032 (USD Billion)

8. Global Cardiac Marker Testing Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Cardiac Marker Testing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Cardiac Marker Testing Market - North America
    • 8.3.1. North America: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
    • 8.3.2. North America: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
    • 8.3.3. North America: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.3.4. Cardiac Marker Testing Market - U.S.
      • 8.3.4.1. U.S.: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.3.5. Cardiac Marker Testing Market - Canada
      • 8.3.5.1. Canada: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • 8.4. Cardiac Marker Testing Market - Europe
    • 8.4.1. Europe: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.4. Cardiac Marker Testing Market - UK
      • 8.4.4.1. UK: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.5. Cardiac Marker Testing Market - France
      • 8.4.5.1. France: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.6. Cardiac Marker Testing Market - Germany
      • 8.4.6.1. Germany: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.7. Cardiac Marker Testing Market - Italy
      • 8.4.7.1. Italy: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.8. Cardiac Marker Testing Market - Spain
      • 8.4.8.1. Spain: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.9. Cardiac Marker Testing Market - Netherlands
      • 8.4.9.1. Netherlands: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.4.10. Cardiac Marker Testing Market - Russia
      • 8.4.10.1. Russia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • 8.5. Cardiac Marker Testing Market - Asia Pacific
    • 8.5.1. Asia Pacific: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.4. Cardiac Marker Testing Market - China
      • 8.5.4.1. China: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.5. Cardiac Marker Testing Market - India
      • 8.5.5.1. India: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.6. Cardiac Marker Testing Market - Malaysia
      • 8.5.6.1. Malaysia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.7. Cardiac Marker Testing Market - Japan
      • 8.5.7.1. Japan: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.8. Cardiac Marker Testing Market - Indonesia
      • 8.5.8.1. Indonesia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.5.9. Cardiac Marker Testing Market - South Korea
      • 8.5.9.1. South Korea: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • 8.6. Cardiac Marker Testing Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.4. Cardiac Marker Testing Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.5. Cardiac Marker Testing Market - UAE
      • 8.6.5.1. UAE: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.6. Cardiac Marker Testing Market - Israel
      • 8.6.6.1. Israel: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.6.7. Cardiac Marker Testing Market - South Africa
      • 8.6.7.1. South Africa: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • 8.7. Cardiac Marker Testing Market - Latin America
    • 8.7.1. Latin America: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.7.4. Cardiac Marker Testing Market - Mexico
      • 8.7.4.1. Mexico: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.7.5. Cardiac Marker Testing Market - Brazil
      • 8.7.5.1. Brazil: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
    • 8.7.6. Cardiac Marker Testing Market - Argentina
      • 8.7.6.1. Argentina: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. F. Hoffmann-La Roche AG
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Abbott Laboratories
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Danaher Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Siemens Healthineers
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Becton Dickson
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Bio-Rad Laboratories
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Thermo Fisher Scientific
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. LSI Medience
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Quidel Corporation
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Randox Laboratories
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. PerkinElmer
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Tosoh Corporation
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Alfa Scientific Designs
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Response Biomedical
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Creative Diagnostics
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development

List of Tables

  • Table 1 Global Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 2 Global Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 3 Global Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 4 Cardiac Marker Testing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 6 North America: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 7 North America: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 8 U.S.: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 9 U.S.: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 10 U.S.: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 11 Canada: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 12 Canada: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 13 Canada: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 14 Europe: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 15 Europe: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 16 Europe: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 17 UK: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 18 UK: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 19 UK: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 20 France: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 21 France: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 22 France: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 23 Germany: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 24 Germany: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 25 Germany: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 26 Italy: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 27 Italy: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 28 Italy: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 29 Spain: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 30 Spain: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 31 Spain: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 35 Russia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 36 Russia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 37 Russia: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 41 China: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 42 China: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 43 China: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 44 India: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 45 India: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 46 India: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 50 Japan: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 51 Japan: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 52 Japan: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 56 South Korea: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 57 South Korea: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 58 South Korea: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 65 UAE: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 66 UAE: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 67 UAE: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 68 Israel: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 69 Israel: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 70 Israel: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 71 South Africa: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 72 South Africa: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 73 South Africa: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 74 Latin America: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 75 Latin America: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 76 Latin America: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 77 Mexico: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 78 Mexico: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 79 Mexico: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 80 Brazil: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 81 Brazil: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 82 Brazil: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)
  • Table 83 Argentina: Cardiac Marker Testing Market, by Product, 2019-2032 (USD Billion)
  • Table 84 Argentina: Cardiac Marker Testing Market, by Application, 2019-2032 (USD Billion)
  • Table 85 Argentina: Cardiac Marker Testing Market, by Biomarker Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Cardiac Marker Testing Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Cardiac Marker Testing Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Product
  • Figure 9. Global Cardiac Marker Testing Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Biomarker Type
  • Figure 11. Global Cardiac Marker Testing Market, by Biomarker Type, 2022 & 2032 (USD Billion)
  • Figure 12. Cardiac Marker Testing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Cardiac Marker Testing Market